$KOPN

Kopin (NASDAQ:KOPN) Stock Price Down 8.4% – Time to Sell?

Kopin (NASDAQ:KOPN) shares fell 8.4% on Friday to about $5.54, after trading as low as $5.56; volume was 1.79M shares versus a 5.51M average. The company reported Q1 EPS of -$0.02 (vs -$0.01 consensus) on revenue of $10.55M (vs $9.96M). Analysts cited mixed ratings, with a consensus target of $7.15.

Original reporting
Published May 29, 2026, 5:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 6:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kopin (NASDAQ:KOPN) Stock Price Down 8.4% – Time to Sell? — source image
Decision brief

The 30-second read

$KOPNBearishMed
01

Why it matters

The combination of an intraday -8.4% move, a reported EPS miss, and recent insider selling increases near-term downside risk and can deter incremental buyers, even with some analyst target increases.

02

Market read

Traders get a same-day tape reaction plus the latest earnings datapoints and insider activity, which together inform risk management for KOPN over the next days/weeks.

03

What to watch

The article highlights insider sales but does not provide whether they were routine/plan-driven beyond Rule 10b5-1; also the stock’s extreme beta and moving averages may be amplifying technical selling.

Relevance 9/10Novelty 6/10Timing: today’s session selloff following the May 12 earnings print

Background

Kopin is a microdisplay/optical components company; the article centers on a sharp Friday decline, the most recent quarterly results (May 12), and disclosed officer sales.

Company-level read

Ticker impact

$KOPNBearishMedium confidence
Context

Kopin shares fell 8.4% on heavy volume after the May 12 quarter missed EPS and insiders sold under Rule 10b5-1 plans.

Expected impact

Bearish-to-choppy trading likely until follow-through on fundamentals or new guidance; any rebound may be limited by insider selling optics.

Evidence & confidence

The article provides a same-day price move, the latest reported quarter (EPS miss, revenue detail), and disclosed officer sales; analyst rating changes are mixed and not a new fundamental catalyst.

Market effects

Microdisplay/AR-VR component names may see sentiment spillover from a high-beta small-cap earnings miss and insider selling optics.

Primarily US small-cap tech sentiment; limited direct regional linkage beyond NASDAQ microcap flows.

Low—no global deal/regulatory catalyst cited; impact likely confined to KOPN and closely held microdisplay peers.

Counterpoint

Analyst price targets were raised by multiple firms and revenue exceeded consensus, suggesting the selloff could be overshooting if guidance stabilizes.

Key entities

  • Kopin Corporation

    Subject of the article; NASDAQ-listed microdisplay company whose stock dropped sharply and recently reported earnings.

  • Michael Andrew Murray

    CEO disclosed sale of 187,920 shares under a Rule 10b5-1 plan (April 13).

  • Paul Christopher Baker

    COO disclosed sale of 116,860 shares under a Rule 10b5-1 plan (April 28).

Related articles

$KOPNHighAI 9/10

Why is Kopin stock surging today?

Kopin Corp (KOPN) shares rose about 26% after the company reported Q2 2026 results above expectations, with revenue of $12.7M versus $11.75M consensus and net income of $0.9M versus a $5.2M loss a year earlier. Kopin also guided to full GAAP profitability by Q4 2026 and said its Neural I/o MicroLED optical interconnect with Fabric.AI remains on track for a CES 2027 demo.

$KOPNMed

KOPIN CORP (KOPN): Results of Operations and Financial Condition

KOPIN CORP (KOPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Kopin Corporation Reports Second Quarter 2026 Financial Results Three Major Milestones Achieved in U.S. Army Color MicroLED Program, Including Record-Setting 150,000+ Nit Full-Color Brightness and Installation of U.S. Bonding Capability,

$ASMLMed

Why ASML Holding Stock Rallied Tuesday Morning

ASML shares rose as much as 5% Tuesday, trading up 3.2% by 12:54 p.m. ET, after Taiwan Semiconductor Manufacturing (TSMC) reported strong July revenue. TSMC net revenue was NT$467.58B (about $14.5B), up 44.7% year over year and 5.6% sequentially, signaling demand for advanced AI chips that supports ASML’s EUV systems.

$TENXMed

A Wild Day In Biotech

Biotech stocks moved sharply after clinical and guidance updates. Tenax Therapeutics (TENX) fell nearly 90% after its Phase 3 LEVEL trial of TNX-103 missed primary and key secondary endpoints. AbCellera Biologics (ABCL) rose on Phase 2 results for ABCL635 in menopausal vasomotor symptoms. 10x Genomics (TXG) gained after raising full-year revenue guidance and citing strong early Atera demand.

$SCWOMed

374Water says preliminary revenue higher in Q2 after key sanitation district contract milestone

374Water Inc (NASDAQ:SCWO) said preliminary Q2 2026 revenue rose to over $2.2 million from $0.6 million a year earlier, mainly from revenue recognized after a Factory Acceptance Test milestone for California’s Orange County Sanitation District (OC San). The milestone enables recognition of remaining $1.1 million and $2.6 million in remaining billings. Full results are due Aug. 14.